ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Journal and News Scan
The authors report seven-year outcomes of the PARTNER 3 trial comparing transfemoral transcatheter aortic valve replacement (TAVR) with surgical aortic valve replacement (SAVR) in 1,000 low-risk patients with severe, symptomatic aortic stenosis. At seven years, there were no significant differences between groups in the primary composite endpoints of death, stroke, or rehospitalization (34.6 percent for TAVR vs 37.2 percent for SAVR; HR 0.87, 95 percent CI 0.70–1.08). Mortality was similar (19.5 percent vs 16.8 percent), as were stroke (8.5 percent vs 8.1 percent), and valve failure (6.9 percent vs 7.3 percent). Valve hemodynamics and patient-reported outcomes remained stable. TAVR resulted in less atrial fibrillation but had higher rates of pacemaker implantation and paravalvular regurgitation.
This international EACTS-endorsed survey assessed current practices and sought consensus on defining periprocedural myocardial infarction (PMI) after coronary artery bypass grafting (CABG). Among 175 respondents from 29 countries, 46.4 percent reported using a specific PMI definition, with the most common being the Universal Definition of Myocardial Infarction (UDMI-4). Proposed biomarker thresholds for PMI varied, depending on the presence of supporting imaging evidence. Respondents emphasized diagnostic sensitivity over specificity (79.8 percent vs 20.2 percent). The study reveals substantial heterogeneity in clinical practice and underscores the need for a standardized CABG-specific PMI definition with high diagnostic accuracy to ensure consistent reporting and clinical interpretation.
This study analyzed 3,394 pediatric congenital heart disease (CHD) patients listed for heart transplant from 2014 to 2023. Of these, 16.5 percent received ventricular assist device (VAD) support while waitlisted. Waitlist mortality was higher in the VAD group (25.7 percent vs 16.2 percent). Among 2,248 transplanted patients, VAD-supported cases showed similar post-transplant events and five-year survival compared to non-VAD patients. VAD use increased from 20 to 73 cases annually. It was concluded that pediatric CHD patients bridged-to-transplant with VAD achieve comparable long-term survival to those without VAD.
The European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS), and The American Association for Thoracic Surgery (AATS) recently released joint consensus guidelines on use of temporary mechanical circulatory support (tMCS). This field has evolved significantly during the past decade. This document comprehensively discusses the goals of tMCS, device selection and various configurations, patient evaluation and selection, as well as contraindications to the use of such devices. These comprehensive guidelines also discuss their role in heart failure, including their use as a bridging strategy, monitoring and anesthetic management in patients with tMCS, postoperative management in the ICU—including ventilator strategies, renal management, anticoagulation techniques—as well as ultimate weaning and explantation techniques.
This article explores the challenges and benefits of growing up with a mother in cardiothoracic (CT) surgery. Through a preliminary survey of 12 adult children of women CT surgeons, the study highlights both positive and negative impacts. Most respondents described their mothers as role models who instilled independence, resilience, problem-solving, and career inspiration. However, limited parental availability due to workload often created emotional distance, particularly during early childhood. The findings emphasize the need for institutional reforms, such as flexible scheduling, parental leave, childcare support, and mentorship, to promote work-life integration. Ultimately, the authors conclude that systemic support is essential to ensure women surgeons can thrive in both career and motherhood.
This study analyzed 32,036 adult heart transplant recipients from 2010 to 2023 to assess long-distance donor (LDD) utilization after the 2018 allocation policy change. LDD use increased from 5.5 percent to 14 percent, with mean donor distance rising from 171 to 288 miles. Risk-adjusted survival was significantly better with LDD at 30-day, 1-year, and 5-year intervals. Distance correlated weakly with ischemia time. Despite increased cold ischemia time (from 3.20 to 3.60 hours), outcomes improved with LDD, suggesting that distance alone does not predict ischemia time or survival.
In this article, the authors analyzed 6,693 redo coronary artery bypass grafting (CABG) operations performed between 1980 and 2020 at the Cleveland Clinic to determine whether multiarterial grafting (MAG) provides a survival benefit over single arterial grafting (SAG). Using propensity-matched cohorts (2,005 pairs), they found that MAG resulted in lower in-hospital mortality (1.7 percent vs 2.8 percent) and comparable morbidity. Long-term survival was significantly better after MAG, particularly in men receiving bilateral internal thoracic artery (ITA) grafts, with a 20-year survival rate of 31 percent compared to 25 percent after SAG. No clear survival advantage was observed in women or when non-ITA conduits were used. The authors note that CABG is technically more complex in women, whose smaller arteries and limited collateralization may partly explain the limited observed benefit.
The EACTS recently released an expert consensus statement on the Ross procedure in adult patients, highlighting the renewed focus in this area due to increasing evidence of excellent long-term outcomes. These outcomes include restoration of life expectancy and improved valve-related outcomes. The Ross procedure is now considered a viable first-line option for selected young and middle-aged adults with nonrepairable aortic valve disease. Currently, its adoption remains inconsistent across institutions, partly due to concerns about surgical complexity, long-term durability, and the need for structured follow-up. This expert consensus statement discusses the rationale for increasing adoption, surgical technique, patient selection, and standardization procedures in centers of excellence.
In this study, the authors evaluated a novel aortic anastomotic stapler for repairing acute type A aortic dissections using a human cadaver model. Ten felt sandwich repairs were performed, with half completed using conventional sutures and the other half using the stapler. The stapler significantly reduced procedure time (median 2:22 vs 6:40 minutes) without increasing leakage. Importantly, the stapled group showed no distal anastomotic new entry, false lumen perfusion, or dissection progression, while these complications occurred in the sutured group. Microscopy confirmed less tissue trauma with the stapler. The device achieved reliable pin deployment and faster, more homogeneous sealing than sutures. While limited to cadaveric testing, these findings suggest this device may improve safety and efficiency in type A dissection repair, warranting further in vivo validation.
This article presents the first comparative analysis of outcomes after tracheobronchoplasty (TBP) for excessive dynamic airway collapse (EDAC) and tracheobronchomalacia (TBM), two distinct but often conflated causes of excessive central airway collapse (ECAC). In this single-center retrospective study of 73 patients (47 with EDAC and 26 with TBM), the authors used dynamic CT imaging reviewed by airway experts to establish a gold-standard diagnosis. Despite anatomical and pathophysiologic differences, postoperative outcomes were comparable between EDAC and TBM in terms of complication rates, intensive care units (ICU) and hospital stays, readmissions, and quality-of-life improvements. Both groups experienced significant gains in respiratory symptoms and six-minute walk test performance following TBP.
The study highlights that while differentiating EDAC from TBM remains diagnostically challenging, these distinctions do not translate into differences in surgical benefit, supporting TBP as a definitive and effective treatment for severe ECAC regardless of the cause. Importantly, the findings underscore the need for refined diagnostic standards, multidisciplinary evaluation, and expanded surgical candidacy criteria.
For the global cardiothoracic surgery audience, this paper is significant because it clarifies disease mechanisms and outcomes for a rare but increasingly recognized cause of airway obstruction. It informs evolving robotic and open TBP approaches, emphasizes the importance of multidisciplinary collaboration between surgeons and interventional pulmonologists, and sets the stage for multicenter efforts to standardize diagnosis and management of complex airway disorders.